Press release
Pulmonary Artery Catheters Market Outlook, and Opportunity Analysis, 2018-2026
Pulmonary artery catheterization, also called Swan-Ganz catheterization, is the procedure which involves insertion of catheter into the right side of the heart and to the arteries that lead to the lungs. It is used in the diagnosis of problems such as to determine the hemodynamic abnormalities in heart and lungs. This catheter allows measurement of pressure in pulmonary artery, right ventricle, and wedge pressure of left atrium.Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/465
The procedure of pulmonary artery catheterization can be used to evaluate risk of heart attack, shock, heart failure, pulmonary edema, cardiomyopathy, pulmonary hypertension and often used to check the complications in the kidneys. The catheters can be used with an IV-through which heart medications can be delivered and the effects of the medications can be monitored and checked by pulmonary artery catheter. Pulmonary artery catheters or Swan-Ganz catheters can be used in combination with an endocardial biopsy and it also helps to determine if medication is needed to lower the blood pressure, as pulmonary heart pressure should be low for heart transplant patients.
Increasing incidence of heart and lung diseases driving the pulmonary catheter market
According to WHO report in 2015, cardiovascular diseases were responsible for 31% of all global death. Rising incipience of cardiovascular diseases creates a highly conducive environment for growth of the pulmonary artery catheter market. Also, high prevalence of diabetes, hypertension, owing to change in lifestyle of people, and smoking and drinking habits further supplements market growth.
The growing number of geriatric population in the world driving the pulmonary artery catheter market. However, there are some restraints in the use of pulmonary artery catheter such as it is not recommended for patients with acute respiratory distress syndrome, septic shocks, and in the routine treatment for patients undergoing high risk of surgery. The most hazardous risk of using pulmonary artery catheter is pulmonary artery rupture and risk to the patients receiving anticoagulation therapy.
The rising number of patients with heart and lung complications owing to increase in use of pulmonary artery catheter in North America
Regional segmentation of pulmonary artery catheter market by Coherent Market Insights comprises North America, Asia Pacific, Europe, Africa, and Middle East. North America region dominates the pulmonary artery catheters market, mainly due to high prevalence of cardiovascular disorder as a result of sedentary lifestyle. The changing lifestyle, unhealthy diet, the increase in people with habits such as smoking and drinking, increase in stress level owing to increase in population of patients which leads to the growth of pulmonary artery catheters market. Followed by North America, Europe and Asia Pacific are also one of the emerging market for pulmonary artery catheter. The change in lifestyle, lack of exercise in people, and increasing geriatric population in this region are some the factors driving growth of the pulmonary artery catheter market in this region.
Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/465
Rapid use of pulmonary artery catheter by physicians is expected to aid pulmonary artery catheter market growth
Key players operating the pulmonary catheter market globally include ICU Medical, argon Medical, Edwards Life Sciences Corporation, Biosensors International and Becton Dickinson (BD). The rapid use of pulmonary artery catheters by physicians in the treatment of heart and lung disorders is expected to drive the pulmonary artery catheters market.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Artery Catheters Market Outlook, and Opportunity Analysis, 2018-2026 here
News-ID: 1182768 • Views: …
More Releases from Coherent Market Insights
U.S. Clinical Laboratory Services Market Exclusive Report with Detailed Study An …
Coherent Market Insights has released a report titled "U.S. Clinical Laboratory Services Market 2025-2032: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins.
➤…
Orthopedic Regenerative Medicine with Detailed Study Analysis 2025-2032 | Anika …
The Orthopedic Regenerative Medicine market is estimated to be valued at USD 11.68 Bn in 2025 and is expected to reach USD 23.79 Bn by 2032, growing at a compound annual growth rate CAGR of 10.7% from 2025 to 2032.
➤ The latest Qualitative Research Report on the Orthopedic Regenerative Medicine Market 2025, published by Coherent Market Insights, delivers in-depth insights into both global and regional markets, which are anticipated to…
Asia Pacific Wound Care Biologics Market Growth in Future Scope 2025-2032 | Smit …
The Asia Pacific Wound Care Biologics market is estimated to be valued at USD 296.1 Mn in 2025 and is expected to reach USD 533.8 Mn by 2032, growing at a compound annual growth rate CAGR of 7.6% from 2025 to 2032.
➤ The qualitative latest Research report (2025-2032) on the Asia Pacific Wound Care Biologics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges,…
Future Scope of Premium Potting Soils Market Set for Significant Growth by 2025 …
The Premium Potting Soils market is estimated to be valued at USD 1,598.4 Mn in 2025 and is expected to reach USD 1,855.1 Mn by 2032, growing at a compound annual growth rate CAGR of 3.5% from 2025 to 2032.
➤ The Latest Report, titled Premium Potting Soils Market includes a detailed analysis of current market conditions, market players, regions, types, applications, Opportunity and Forecast 2025-2032. The report provides a detailed…
More Releases for Pulmonary
Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,…
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
